Nav: Home

Genetic mutation drives tumor regression in Tasmanian Devils

November 28, 2018

Washington State University scientists have discovered genes and other genetic variations that appear to be involved in cancerous tumors shrinking in Tasmanian devils.

Their research is an important first step towards understanding what is causing devil facial tumor disease, a nearly 100 percent fatal and contagious form of cancer, to go away in a small percentage of Tasmanian devils and could have implications for treating cancer in humans and other mammals as well.

"Some of the genes we think have a role in tumor regression in Tasmanian devils are also shared by humans," said Mark Margres, a former WSU postdoctoral researcher now at Clemson University. "While still in a very early stage, this research could eventually help in the development of drugs that elicit the tumor regression response in devils, humans and other mammals that don't have this necessary genetic variation."

Disappearing Devils

Tasmanian devils have been pushed to the brink of extinction by the rapid spread of devil facial tumor disease, one of only four known forms of transmissible cancer and by far the deadliest. Since it was first documented in 1996, the disease has wiped out an estimated 80 percent of devils in Tasmania, the only place in the world where the animals live.

Margres is part of an international team of researchers studying devil facial tumor disease that is led by Andrew Storfer, an evolutionary geneticist and WSU professor of biology.

For the last decade, Storfer's team has been investigating how some Tasmanian devil populations are evolving genetic resistance to devil facial tumor disease that could help the species avoid extinction.

A year ago, Storfer's Australian collaborators, Manuel Ruiz, Rodrigo Hamede and Menna Jones noticed something very unusual while trapping and tagging devils in an isolated region of Tasmania. A very small number of devils that developed facial tumors did not die. Rather, over a period of several months, the tumors went away on their own.

"This was very unusual and we wanted to test for evidence of genomic variation that was causing these devils to spontaneously get better" Storfer said.

The researchers sequenced the genomes of seven of the Tasmanian devils that underwent tumor regression and three that did not.

They found the devils that lost their tumors had three highly differentiated genomic regions containing multiple genes that are known to be related to immune response and cancer risk in humans and other mammals.

"We identified some candidate genes that we think may be important in the tumor regression response and now we can begin to functionally test these genes to see if it is possible to elicit the same tumor regression response," Margres said. "While it is hard to say anything definite with such a small sample size, I think this research is sort of the first step towards characterizing the genetic basis of the tumor regression trait."

The results of Margres and Storfer's work were published last month in the journal Genome Biology and Evolution. The researchers said the next step in the research is to analyze the tumor genome to see if there are specific mechanisms or mutations there that lead to tumor shrinkage.

Uncovering mechanisms of tumor regression

Tumor regression is not a phenomenon exclusive to Tasmanian devils. While extremely rare, it has been documented in human cancers.

One such cancer is Merkel Cell Carcinoma, a rare type of skin cancer that often appears on the face, head or neck.

Doctors observed spontaneous tumor regression in a Merkel Cell Carcinoma patient for the first time in 1986 and it has occurred at least 22 times since. However, researchers remain unsure of what causes the tumors to go away on their own.

Storfer and Margres hope is that developing a better understanding of the genetic basis of tumor regression in Tasmanian devils may eventually enable the identification of general mechanisms underlying tumor regression in Merkel Cell Carcinoma and other human cancers.
-end-


Washington State University

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Space
One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at Radiolab.org/donate.